Polypharmacy in a Patient With Intellectual and Developmental Disabilities - PubMed (original) (raw)

Case Reports

. 2022 Feb 8;14(2):e22019.

doi: 10.7759/cureus.22019. eCollection 2022 Feb.

Affiliations

• PMID: 35282537
• PMCID: PMC8908801
• DOI: 10.7759/cureus.22019

Case Reports

Polypharmacy in a Patient With Intellectual and Developmental Disabilities

Rishi Raj et al. Cureus. 2022.

Abstract

Prader-Willi syndrome (PWS) is an uncommon condition and its clinical manifestation in adulthood includes central obesity, hypogonadism, osteoporosis, cardiovascular disease, diabetes mellitus, and sleep apnea. These patients often have mild to moderate intellectual disability and are dependent upon their caregiver for healthcare needs. Hence, they may be at increased risk of polypharmacy-related complications, if there is poor communication between healthcare providers and caregivers. We present a case of a 26-year-old adult with PWS and mild to moderate intellectual disability, who was found to have acute kidney injury resulting from drug interaction between multiple nephrotoxic medications. Our case report highlights the importance of continuity of care with primary care providers, especially in patients with intellectual and developmental disabilities (IDD).

Keywords: acute kidney injury; drugs; intellectulaly and developmental disabilities; polypharmacy; prader-willi syndrome.

Copyright © 2022, Raj et al.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

• High levels of caregiver burden in Prader-Willi syndrome.
  Kayadjanian N, Schwartz L, Farrar E, Comtois KA, Strong TV. Kayadjanian N, et al. PLoS One. 2018 Mar 26;13(3):e0194655. doi: 10.1371/journal.pone.0194655. eCollection 2018. PLoS One. 2018. PMID: 29579119 Free PMC article.
• Hassles with medication management perceived by caregivers of adults who have intellectual or developmental disabilities.
  Erickson SR, Yang Y. Erickson SR, et al. Int J Clin Pharm. 2019 Feb;41(1):131-140. doi: 10.1007/s11096-018-0771-0. Epub 2018 Dec 22. Int J Clin Pharm. 2019. PMID: 30578472
• Study of the deficit in planning abilities of adults with Prader-Willi Syndrome.
  Estival S, Chevalère J, Laurier V, Mourre F, Tricot J, Postal V. Estival S, et al. Res Dev Disabil. 2021 Oct;117:104056. doi: 10.1016/j.ridd.2021.104056. Epub 2021 Aug 6. Res Dev Disabil. 2021. PMID: 34371306
• Healthcare transition in persons with intellectual disabilities: general issues, the Maastricht model, and Prader-Willi syndrome.
  Schrander-Stumpel CT, Sinnema M, van den Hout L, Maaskant MA, van Schrojenstein Lantman-de Valk HM, Wagemans A, Schrander JJ, Curfs LM. Schrander-Stumpel CT, et al. Am J Med Genet C Semin Med Genet. 2007 Aug 15;145C(3):241-7. doi: 10.1002/ajmg.c.30136. Am J Med Genet C Semin Med Genet. 2007. PMID: 17639594 Review.
• Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
  Muscogiuri G, Barrea L, Faggiano F, Maiorino MI, Parrillo M, Pugliese G, Ruggeri RM, Scarano E, Savastano S, Colao A; RESTARE. Muscogiuri G, et al. J Endocrinol Invest. 2021 Oct;44(10):2057-2070. doi: 10.1007/s40618-021-01574-9. Epub 2021 Apr 23. J Endocrinol Invest. 2021. PMID: 33891302 Free PMC article. Review.

Cited by

• Kidney disease in adults with Prader-Willi syndrome: international cohort study and systematic literature review.
  van Abswoude DH, Pellikaan K, Nguyen N, Rosenberg AGW, Davidse K, Hoekstra FME, Rood IM, Poitou C, Grugni G, Høybye C, Markovic TP, Caixàs A, Crinò A, van den Berg SAA, van der Lely AJ, de Graaff LCG. van Abswoude DH, et al. Front Endocrinol (Lausanne). 2023 Jul 21;14:1168648. doi: 10.3389/fendo.2023.1168648. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37547314 Free PMC article.

References

1. 1. The global Prader-Willi syndrome registry: development, launch, and early demographics. Bohonowych J, Miller J, McCandless SE, Strong TV. Genes (Basel) 2019;10:713. - PMC - PubMed
2. 1. Adverse Medication Events Related to Hospitalization in the United States: A Comparison Between Adults With Intellectual and Developmental Disabilities and Those Without. Erickson SR, Kamdar N, Wu CH. Am J Intellect Dev Disabil. 2020;125:37–48. - PubMed
3. 1. Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines. Sullivan WF, Diepstra H, Heng J, et al. https://pubmed.ncbi.nlm.nih.gov/29650602/ Can Fam Physician. 2018;64:254–279. - PMC - PubMed
4. 1. Prader-Willi syndrome: current understanding of cause and diagnosis. Butler MG. Am J Med Genet. 1990;35:319–332. - PMC - PubMed
5. 1. Prader-Willi syndrome. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Genet Med. 2012;14:10–26. - PubMed

Publication types

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central